You are hereBiblio / Opinion: Gene patenting and medical research: a view from a pharmaceutical company
Opinion: Gene patenting and medical research: a view from a pharmaceutical company
| Title | Opinion: Gene patenting and medical research: a view from a pharmaceutical company |
| Publication Type | Journal Article |
| Year of Publication | 2004 |
| Authors | Stott, Mike, and Valentine Jill |
| Journal | Nature Reviews Drug Discovery |
| Volume | 3 |
| Issue | 4 |
| Pagination | 364-368 |
| Type of Article | Article |
| Publication Language | eng |
| ISSN Number | 14741776 |
| Accession Number | 12728644 |
| Keywords | Drug , Drugs , MEDICINE , PATENTS , Pharmaceutical |
| Abstract | In this article the authors seek to evaluate the impact of gene patenting objectively by examining, in overall terms, whether there has been a net cost or benefit to medical research from gene patenting. |
| Notes | Stott, Mike 1; Email Address: jill.b.valentine@gsk.com Valentine, Jill 1; Email Address: mike.j.stoll@gsk.com; Affiliation: 1: Corporate Intellectual Property, Glaxo Smith Khine plc, 980, Great West Road, Brentford, Middlesex, TW8 9GS, UK.; Source Info: Apr2004, Vol. 3 Issue 4, p364; Subject Term: PHARMACEUTICAL industry; Subject Term: PATENTS; Subject Term: MEDICINE -- Research; Subject Term: DRUGS -- Research; Subject Term: DRUGS -- Design; Subject Term: DRUG development; NAICS/Industry Codes: 541712 Reseach and Development in the Physical, Engineering, and Life Sciences (except Biotechnology); NAICS/Industry Codes: 325412 Pharmaceutical Preparation Manufacturing; Number of Pages: 5p; Document Type: Article |
| DOI | 10.1038/nrd1348 |
